Literature DB >> 15939811

Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor.

Joanna Shepherd1, Martin J H Nicklin.   

Abstract

BACKGROUND: In mice that lack interleukin-1 receptor antagonist (IL-1ra), transmural inflammation of the elastic arteries develops at sites of turbulent flow. We described late histopathology previously. Here, we investigate the cellular events in nonlethal arteritis at the aortic root and compare them with Takayasu's arteritis and giant cell arteritis. METHODS AND
RESULTS: IL-1ra-deficient mice were inbred from the original stocks and from BALB/c backcrosses. Disease was ascertained histologically and immunohistologically postmortem at the aortic root. Onset appeared to be stochastic and was not detectably age dependent; in our local Sf3 strain, the half-time of onset was approximately 52 days. Loss of the type I IL-1 receptor suppressed the arteritis. Microvascular activation, as determined by absence of strong E-selectin expression, was absent from preaffected vessels. In mildly affected cases, infiltration was adventitial. In severely affected animals, infiltrates appeared to be active in destroying elastin, but resynthesis of disorganized elastin occurred at closely adjacent sites. Infiltrates consisted predominantly of macrophages but were rich in CD4+-interferon-gamma+ cells, which are likely to represent Th1 cells. Dendritic cells accumulated in lesional areas.
CONCLUSIONS: The arteritic phenotype of IL-1ra deficiency is mediated by the interleukin-1 receptor and involves effector Th1 cells. The destructive pattern and many of the cellular features of arteritis in IL-1ra-deficient mice resemble the human elastic-vessel arteritides, for which these mice may be a useful animal model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939811     DOI: 10.1161/CIRCULATIONAHA.104.519132

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

1.  Impact of IL-1 signalling on experimental uveitis and arthritis.

Authors:  Stephen R Planck; April Woods; Jenna S Clowers; Martin J Nicklin; James T Rosenbaum; Holly L Rosenzweig
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

2.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 3.  Giant cell arteritis: Current treatment and management.

Authors:  Cristina Ponte; Ana Filipa Rodrigues; Lorraine O'Neill; Raashid Ahmed Luqmani
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

Review 4.  Biologic Therapy for the Treatment of Giant Cell Arteritis.

Authors:  Rochella A Ostrowski; Melissa R Bussey; Rodney Tehrani; Walter Jay
Journal:  Neuroophthalmology       Date:  2014-04-02

5.  Aberrant interleukin-1 signalling does not increase susceptibility of mice to NOD2-dependent uveitis.

Authors:  Ellen J Lee; Jordan J Allensworth; Jenna S Clowers; Holly L Rosenzweig
Journal:  Clin Exp Ophthalmol       Date:  2014-10-30       Impact factor: 4.207

6.  Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis.

Authors:  Kira Minkis; Ivona Aksentijevich; Raphaela Goldbach-Mansky; Cynthia Magro; Rachelle Scott; Jessica G Davis; Niti Sardana; Ronit Herzog
Journal:  Arch Dermatol       Date:  2012-06

Review 7.  Update on the management of giant cell arteritis.

Authors:  Janet Roberts; Alison Clifford
Journal:  Ther Adv Chronic Dis       Date:  2017-03-28       Impact factor: 5.091

8.  Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms.

Authors:  Rumin He; Dong-Chuan Guo; Wei Sun; Christina L Papke; Senthil Duraisamy; Anthony L Estrera; Hazim J Safi; Chul Ahn; L Maximilian Buja; Frank C Arnett; Jingwu Zhang; Yong-Jian Geng; Dianna M Milewicz
Journal:  J Thorac Cardiovasc Surg       Date:  2008-06-12       Impact factor: 5.209

9.  Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).

Authors:  Sotirios Tsimikas; Gordon W Duff; Peter B Berger; John Rogus; Kenneth Huttner; Paul Clopton; Emmanuel Brilakis; Kenneth S Kornman; Joseph L Witztum
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

Review 10.  Giant Cell Arteritis: 2018 Review.

Authors:  Anne Winkler; David True
Journal:  Mo Med       Date:  2018 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.